Filter Run Time in CVVH: Pre- versus Post-Dilution and Nadroparin versus Regional Heparin-Protamine Anticoagulation
- 1 May 2005
- journal article
- clinical trial
- Published by S. Karger AG in Blood Purification
- Vol. 23 (3), 175-180
- https://doi.org/10.1159/000083938
Abstract
Background/Aims: To study the effect of different modes of continuous veno-venous haemofiltration (CVVH) on filter run time (FRT). Methods: We studied, in two consecutive prospective, randomised and crossover studies, 16 and 15 patients with acute renal failure during critical illness. Study A compared pre- versus post-dilution, and study B compared regional anticoagulation with heparin (pre-filter) and protamine (post-filter) (HP) versus nadroparin (NP) pre-filter. All CVVH sessions were standardised. Analyses were by Wilcoxon rank sum tests. Results: Study A: During pre-dilution the median FRT was 45.7 vs. 16.1 h in post-dilution CVVH (p = 0.005). The median creatinine clearance during pre-dilution was 33 vs. 45 ml/min in post-dilution (p = 0.001). Study B: During NP, median FRT was 39.5 vs. 12.3 h during HP CVVH (p = 0.045). Conclusions: Pre-dilution CVVH results in the greatest FRT but a lower plasma creatinine clearance compared to post-dilution. Regional anticoagulation with heparin-protamine resulted in a significantly shorter FRT compared to systemic NP anticoagulation.Keywords
This publication has 11 references indexed in Scilit:
- Pre-Dilution vs. Post-Dilution during Continuous Veno-Venous Hemofiltration: Impact on Filter Life and Azotemic ControlNephron Clinical Practice, 2003
- The Acute Dialysis Quality Initiative—Part VI: Access and anticoagulation in CRRTAdvances in Renal Replacement Therapy, 2002
- Hirudin versus heparin for anticoagulation in continuous renal replacement therapyIntensive Care Medicine, 2001
- The impact of haemofiltration on the systemic cardiovascular responseNephrology Dialysis Transplantation, 2000
- Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover studyCritical Care Medicine, 2000
- Anticoagulation in continuous renal replacement therapyCurrent Opinion in Nephrology and Hypertension, 1999
- A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtrationCritical Care Medicine, 1999
- Continuous renal replacement therapy in the intensive care unitIntensive Care Medicine, 1999
- Systemic and Pulmonary Circulatory Effects of Protamine Following Cardiopulmonary Bypass in ManScandinavian Journal of Thoracic and Cardiovascular Surgery, 1991
- APACHE IICritical Care Medicine, 1985